Midgard Science

Rentschler Biopharma

Laupheim, Germany rentschler-biopharma.com From their website, Nov 2026

  • GMP

Work here? Claim this listing

About

Rentschler Biopharma is a biopharmaceutical CDMO serving customers developing and manufacturing biopharmaceuticals from concept through market launch. It works with clients on process development, analytical development, formulation development, cGMP manufacturing, program management, and regulatory support at its sites in Laupheim and Milford.

Services

  • Biopharmazie

    Provides full-service solutions for bioprocess development and manufacturing of biopharmaceuticals.

  • Analytische Entwicklung

    Develops, establishes, qualifies, validates, and transfers analytical methods for biopharmaceutical products across clinical phases to commercial cGMP production.

  • Prozessentwicklung

    Develops, optimizes, and characterizes upstream and downstream manufacturing processes for recombinant proteins and other complex molecules.

  • cGMP Herstellung

    Manufactures drug substance in cGMP-compliant facilities for clinical studies and commercial supply.

    CDMO: development & manufacturing

  • Development Services

    Offers tailored development service models called Velocity, Flexibility, and Liberty for different project phases and needs.

  • Formulierungsentwicklung

    Develops formulations for simple and complex biopharmaceutical modalities from concept to market readiness.

  • Xpert Alliance

    Provides integrated DS-to-DP collaboration with Vetter to streamline processes and shorten time to market.

  • Client Program Management

    Coordinates customer and internal teams, serves as main contact for CMC discussions, and supports program management for complex projects.

1 more services
  • Regulatorische Beratung
Minimums and prices
Velocity liefert eine definierte DS-Menge zu einem Festpreis für mAbs und mAb-likes.

Capabilities

Assays and studies
  • Method development
  • Method transfer
  • Critical quality attribute analysis
Scale and capacity
  • Freigegebene Arzneimittelsubstanz für klinische Phase I/II-Projekte
  • Clinical and commercial cGMP production
  • Pilot scale

Instruments and platforms

  • Massenspektrometrie
  • Mass Spectrometry Facility
  • Filtration

Modalities and species

Modalities
  • Antibody
  • Recombinant protein
  • Biosimilar
Species and models
  • Standard IgGs
  • Producer Pool Proof of Concept

Certifications

As the company states them, with the certificate or registry record where there is one.

  • GMPSelf-reported

    Scope: development and manufacturing

Details

Type
CRDMO
Based in
Laupheim, Germany
Sites
Milford, United States
Serves
Global, Europe, US, APAC, Canada, Latin America, MENA
General enquiry
info@rentschler-biopharma.com on their site

Public records

Parent company
Rentschler Biopharma SE · DE GLEIF
FDA drug establishment registration
1000291122 · ANALYSIS; API MANUFACTURE; MANUFACTURE source

Similar labs